SCHEMBL10123536

SCHEMBL10123536

CC(F)(F)C(C)(NC(=O)N1CCN(c2ccccc2)CC1)C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.56
POLB P06746 3/20 0.50
HTT P42858 2/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 2/20 0.50
USP2 O75604 2/20 0.50
KMT2A Q03164 2/20 0.50
HCRTR1 O43613 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GLA P06280 1/20 0.48
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122256 0.94 MAPK1 (0.58) MAPK1POLBHTTMAPTMEN1
SCHEMBL10123588 0.79 NPC1 (0.50) HTTMAPTCYP2C19LMNASMN1; SMN2
SCHEMBL13993504 0.76 GAA (0.45) POLBHTTMEN1KMT2ALMNA
SCHEMBL10123579 0.75 GAA (0.44) POLBHTTMEN1KMT2ACYP1A2
SCHEMBL11056826 0.75 MAPT (0.62) MAPK1POLBHTTMAPTMEN1
SCHEMBL10123383 0.75 GAA (0.44) POLBHTTMEN1KMT2ACYP1A2
SCHEMBL10122318 0.73 NPC1 (0.52) HTTMAPTCYP2C19LMNASMN1; SMN2
SCHEMBL1576239 0.71 MAPK1 (0.76) MAPK1POLBHTTMAPTMEN1
SCHEMBL8241506 0.71 MAPK1 (0.66) MAPK1POLBMAPTMEN1USP2
SCHEMBL11049712 0.71 GAA (0.68) MAPK1POLBHTTMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012060820-A1 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2012-05-10 WO disclosed
WO-2008147474-A2 SULFONYL SEMICARBAZIDES, CARBONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2008-12-04 WO disclosed